Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Joslin Scientists Find That Salsalate… >

Joslin Scientists Find That Salsalate Lowers Blood Glucose in Type 2 Diabetes

Published: July 2, 2013.
Released by Joslin Diabetes Center  

BOSTON – July 1, 2013 -- Joslin scientists report that salsalate, a drug used to treat arthritis, lowers blood glucose and improves glycemic control in type 2 diabetes. These findings, which were published today by the Annals of Internal Medicine, provide additional evidence that salsalate may be an effective drug to treat type 2 diabetes.

The scientists became interested in studying salsalate, an anti-inflammatory drug, after research conducted by Steven Shoelson, M.D., Ph.D., Head of the Section on Pathophysiology and Molecular Pharmacology and Professor of Medicine at Harvard Medical School, identified inflammation as a factor in the development of type 2 diabetes.

Stage 1 of TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) evaluated varying doses of salsalate in 108 participants with type 2 diabetes for 14 weeks. This study was reported in the Annals of Internal Medicine in 2010. The current findings are based on Stage 2 of TINSAL-T2D, which evaluated 286 participants with type 2 diabetes for 48 weeks. The subjects' blood glucose was inadequately controlled on current diabetes medications. Participants were randomized into salsalate and placebo groups.

After 48 weeks of treatment, the mean hemoglobin A1c level (a measurement of average blood glucose control over the past six to twelve weeks) was 37 percent lower in the salsalate group compared to the placebo group. The decrease in fasting glucose concentration was 15 mg/dl greater in the salsalate group than the placebo group. Patients in the salsalate group required fewer additional diabetes medications to control their blood sugar than patients in the placebo group.

"It's exciting that salsalate is effective in lowering blood sugar," says Allison Goldfine, M.D., lead author and Head of the Section of Clinical, Behavioral and Outcomes Research, and an Associate Professor of Medicine at Harvard Medical School. "Salsalate may have an important role in diabetes treatment and may also help us learn more about how inflammation contributes to the development of type 2 diabetes."

The salsalate group also showed improvements in markers associated with coronary risk: a 9 percent reduction in triglycerides and a 27 percent increase in adiponectin, a potentially cardioprotective protein from adipocytes. Uric acid, which is associated with cardiometabolic conditions and progression of renal disease, decreased 18 percent in the salsalate group. "The reductions in these cardiovascular risk factors paralleled improved glycemia," says Dr. Goldfine. However, the salsalate group also exhibited modest increases in LDL cholesterol and urine albumin, and had a slight increase in weight, which can indicate negative effects on heart or kidney function.

Salsalate's anti-inflammatory effects were evidenced by reductions in circulating white blood cells, neutrophils and lymphocytes, which are elevated in obesity and metabolic syndrome, but all remained within normal range.

The next step in determining whether salsalate is a safe drug for use as a diabetes medication and can receive FDA approval is to assess its effects on the progression of heart disease. Dr. Goldfine is currently leading a study, TINSAL-CVD, which is evaluating how salsalate affects coronary artery plaque volume in participants with established coronary artery disease. The results should be available in two years. "The study will help us better understand the risk/benefit ratio of using salsalate to treat diabetes," says Dr. Goldfine.




The above story is based on materials provided by Joslin Diabetes Center.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

Risk 
4/27/10 
Adding Coronary Calcium Score to Traditional Risk Factors Improves Risk Assessment for Heart Disease
Including a coronary artery calcium score in a risk assessment for future heart disease events, such as heart attacks, provides a better estimate in some populations than a standard …
Risk 
12/23/13 
Study Shows Value of Calcium Scan in Predicting Heart Attack, Stroke among Those Considered at Risk
A new study shows that coronary artery calcium (CAC) screening, an assessment tool that is not currently recommended for people considered at low risk, should play a more prominent …
Disease 
3/31/14 
Celiac Disease Linked to Increased Risk of Coronary Artery Disease
People with celiac disease may have a near two-fold increased risk of coronary artery disease compared with the general population, according to research to be presented at the American …
Coronary 
9/28/11 
★★★ 
Genetic Variant Linked to Blocked Heart Arteries in Patients with Diabetes
Researchers at Washington University School of Medicine in St. Louis have identified the first genetic variant associated with severity of coronary artery disease in patients with type 2 diabetes. …
Disease 
11/18/13 
Physical Fitness Improves Survival, Prevents Some Heart Attacks
A new study highlights the importance of exercise and physical fitness among people with stable coronary artery disease. Researchers at the Johns Hopkins University School of Medicine and Henry …
Dysfunction 
11/18/14 
Early Detectable Vascular Disease Linked to Erectile Dysfunction
Men who have asymptomatic subclinical vascular disease are more likely to develop erectile dysfunction than men who don't have early stage vascular disease, according to research presented at the …
Coronary 
3/7/13 
Rehab Associated with Reduced Risk of Death in Women with CAD
SAN FRANCISCO (March 7, 2013) —Women with coronary artery disease who completed a 12-week cardiac rehabilitation program were two-thirds less likely to die compared to those who were not …
Men 
6/18/13 
Scientists Find Potential Genetic Drivers Behind Male Heart Disease Risk
University of Leicester scientists have discovered a potential genetic contributor to the increased risk of heart disease among men. A team of researchers including clinicians and scientists have …
Disease 
5/7/13 
Type 1 Diabetes And Heart Disease Linked by Inflammatory Protein
NEW YORK, NY (May 7, 2013) — Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood …
Average 
5/20/10 
Increased Use of Drug-eluting Stents, ICDs Nets Higher Costs for Patients
Increased use of drug-eluting stents (DES) and implantable cardioverter-defibrillators (ICDs) between 2003 and 2006 netted significantly higher costs for coronary artery disease and chronic heart failure patients, researchers said. …
Heart 
3/16/10 
Mount Sinai Researchers Are the First to Identify Heart Abnormalities in World Trade Center Workers
Researchers from Mount Sinai School of Medicine are presenting more than 20 ground-breaking studies at the American College of Cardiology (ACC) 59th annual scientific session (ACC.10) in Atlanta. Their …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile